Wie geht es weiter mit Januskinase-Inhibitoren bei rheumatoider Arthritis?
Crossref DOI link: https://doi.org/10.1007/s15002-023-4409-9
Published Online: 2023-10-10
Published Print: 2023-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schäringer, Katja
Text and Data Mining valid from 2023-10-01
Version of Record valid from 2023-10-01
Article History
First Online: 10 October 2023